Literature DB >> 19357939

CCL18 production is decreased in alveolar macrophages from cigarette smokers.

Florian Kollert1, Corina Probst, Joachim Müller-Quernheim, Gernot Zissel, Antje Prasse.   

Abstract

It is generally known that cigarette smoke alters the activation of alveolar macrophages (AM). CC Chemokine Ligand 18 (CCL18) is a marker of alternatively activated macrophages and is highly expressed in the lung. This study examines the influence of chronic cigarette smoking on the expression of CCL18 by AM. Bronchoalveolar lavage (BAL) and serum were obtained from ten smokers and 14 non-smokers. CCL18 protein concentrations were measured in serum and BAL fluid (BALF) as well as in supernatants from BAL-cells by enzyme-linked immunosorbent assay. In this study we show that the CCL18 production of BAL-cells from smokers was significantly decreased compared to BAL-cells from non-smokers. The BALF CCL18 protein concentration per macrophage cell count was significantly reduced in smokers. Furthermore, we show a decrease in CCL18 production from BAL-cells after stimulation with LPS. This decrease in CCL18 production was only shown in BAL-cells from non-smokers, which is probably due to chronic LPS exposure of smokers, resulting in LPS hypo-responsiveness. No statistically significant difference of CCL18 concentrations was found in BALF or serum of smokers versus non-smokers. CCL18 production by BAL-cells is down-regulated by chronic cigarette smoking and LPS contamination in cigarette smoke might be one factor involved. Thus this article gives further evidence that chronic cigarette smoking alters the phenotype of AM and that the M2 marker CCL18 is down-regulated in smokers macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357939     DOI: 10.1007/s10753-009-9115-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages.

Authors:  L Salez; V Balloy; N van Rooijen; M Lebastard; L Touqui; F X McCormack; M Chignard
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

2.  Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.

Authors:  Adriana Heguy; Timothy P O'Connor; Karsta Luettich; Stefan Worgall; Adam Cieciuch; Ben-Gary Harvey; Neil R Hackett; Ronald G Crystal
Journal:  J Mol Med (Berl)       Date:  2006-03-07       Impact factor: 4.599

3.  Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

Authors:  V Cottin; H Nunes; P-Y Brillet; P Delaval; G Devouassoux; I Tillie-Leblond; D Israel-Biet; I Court-Fortune; D Valeyre; J-F Cordier
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

Review 4.  Smad3 signaling involved in pulmonary fibrosis and emphysema.

Authors:  Jack Gauldie; Martin Kolb; Kjetil Ask; Gail Martin; Philippe Bonniaud; David Warburton
Journal:  Proc Am Thorac Soc       Date:  2006-11

5.  A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes.

Authors:  K Hieshima; T Imai; M Baba; K Shoudai; K Ishizuka; T Nakagawa; J Tsuruta; M Takeya; Y Sakaki; K Takatsuki; R Miura; G Opdenakker; J Van Damme; O Yoshie; H Nomiyama
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

6.  Bacterial endotoxin is an active component of cigarette smoke.

Authors:  J D Hasday; R Bascom; J J Costa; T Fitzgerald; W Dubin
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

7.  Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis.

Authors:  R Bingisser; R Speich; A Zollinger; E Russi; K Frei
Journal:  Respiration       Date:  2000       Impact factor: 3.580

Review 8.  COPD: a dust-induced disease?

Authors:  Carlos E Girod; Talmadge E King
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

9.  Estimates of global mortality attributable to smoking in 2000.

Authors:  Majid Ezzati; Alan D Lopez
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

10.  Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts.

Authors:  Sergei P Atamas; Irina G Luzina; Jung Choi; Natalya Tsymbalyuk; Nicholas H Carbonetti; Ishwar S Singh; Maria Trojanowska; Sergio A Jimenez; Barbara White
Journal:  Am J Respir Cell Mol Biol       Date:  2003-06-12       Impact factor: 6.914

View more
  8 in total

1.  Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.

Authors:  Don D Sin; Bruce E Miller; Annelyse Duvoix; S F Paul Man; Xuekui Zhang; Edwin K Silverman; John E Connett; Nicholas A Anthonisen; Robert A Wise; Donald Tashkin; Bartolome R Celli; Lisa D Edwards; Nicholas Locantore; William Macnee; Ruth Tal-Singer; David A Lomas
Journal:  Am J Respir Crit Care Med       Date:  2011-01-07       Impact factor: 21.405

2.  Macrophage-derived biomarkers of idiopathic pulmonary fibrosis.

Authors:  E Bargagli; A Prasse; C Olivieri; J Muller-Quernheim; P Rottoli
Journal:  Pulm Med       Date:  2010-11-29

3.  Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.

Authors:  Lisette I Z Kunz; Thérèse S Lapperre; Jiska B Snoeck-Stroband; Simona E Budulac; Wim Timens; Simone van Wijngaarden; Jasmijn A Schrumpf; Klaus F Rabe; Dirkje S Postma; Peter J Sterk; Pieter S Hiemstra
Journal:  Respir Res       Date:  2011-03-22

4.  Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history.

Authors:  Reza Karimi; Göran Tornling; Johan Grunewald; Anders Eklund; C Magnus Sköld
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

5.  Exposure to diesel exhaust particle extracts (DEPe) impairs some polarization markers and functions of human macrophages through activation of AhR and Nrf2.

Authors:  Marie Jaguin; Olivier Fardel; Valérie Lecureur
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

6.  Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema.

Authors:  Mariana A Antunes; Soraia C Abreu; Fernanda F Cruz; Ana Clara Teixeira; Miquéias Lopes-Pacheco; Elga Bandeira; Priscilla C Olsen; Bruno L Diaz; Christina M Takyia; Isalira P R G Freitas; Nazareth N Rocha; Vera L Capelozzi; Débora G Xisto; Daniel J Weiss; Marcelo M Morales; Patricia R M Rocco
Journal:  Respir Res       Date:  2014-10-03

7.  Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.

Authors:  Asli Gorek Dilektasli; Ezgi Demirdogen Cetinoglu; Esra Uzaslan; Ferah Budak; Funda Coskun; Ahmet Ursavas; Ilker Ercan; Ercument Ege
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-05

8.  Ghrelin therapy improves lung and cardiovascular function in experimental emphysema.

Authors:  Nazareth de Novaes Rocha; Milena Vasconcellos de Oliveira; Cássia Lisboa Braga; Gabriela Guimarães; Lígia de Albuquerque Maia; Gisele de Araújo Padilha; Johnatas Dutra Silva; Christina Maeda Takiya; Vera Luiza Capelozzi; Pedro Leme Silva; Patricia Rieken Macedo Rocco
Journal:  Respir Res       Date:  2017-11-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.